Poll

Preparing for PDT Coverage

06/15/2023

To learn more about PDT coverage through exclusive industry leader insight into PDT market access, evaluation, and delivery, visit the excellence forum.

To read more on payer trends in contracting and disease management, click here.

© 2023 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of First Report Managed Care or HMP Global, their employees, and affiliates.

Behind the Bill

The Nondelegation Doctrine: The Next Constitutional Showdown (Part 1)

02/12/2025

Katie Hayes , MJ;

Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...

Just when you thought the dust...

02/12/2025

First Report Managed Care

Behind the Bill

No, President Trump Did Not Actually Sign an Executive Order That Would Increase Drug Costs for Beneficiaries

02/05/2025

Katie Hayes , MJ;

On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...

On inauguration day, President...

02/05/2025

First Report Managed Care

Behind the Bill

Robert F. Kennedy Jr’s Confirmation and the Unexpected Turn in the Drug Pricing Debate

01/29/2025

Katie Hayes , MJ;

The Plot Thickens in Drug Pricing Drama Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...

The Plot Thickens in Drug...

01/29/2025

First Report Managed Care

Behind the Bill

Medicare Drug Negotiations 2.0: New Administration, Same Mission?

01/22/2025

Katie Hayes , MJ;

Last week brought 2 major developments in health care policy: President Trump's inauguration and the Centers for Medicare and Medicaid Services’ (CMS) announcement of 15 additional drugs selected for Medicare price negotiations. While these...

Last week brought 2 major...

01/22/2025

First Report Managed Care

Behind the Bill

The First 100 Days: Health Care's Critical Deadlines in 2025

01/15/2025

Katie Hayes , MJ;

The 119th Congress faces immediate health care deadlines amid significant leadership transitions. While much attention focuses on high-profile nominations like Dr Oz for Centers for Medicare and Medicaid Services (CMS) Administrator and...

The 119th Congress faces...

01/15/2025

First Report Managed Care

Behind the Bill

Trump's Executive Orders in a Post-Chevron World: Implications for Health Care Policy

01/08/2025

Katie Hayes , MJ;

Happy New Year! As we dive into 2025, it’s clear that this year promises to bring significant changes to health care. With President-elect Donald Trump's inauguration just weeks away, the spotlight is already shifting to how his...

Happy New Year! As we dive into...

01/08/2025

First Report Managed Care

Behind the Bill

A Tale of Two Congresses—Health Care Policy in the 117th vs 118th

12/18/2024

Katie Hayes , MJ;

The 118th Congress is wrapping up with a whimper rather than a bang when it comes to health care legislation, particularly compared to its predecessor's transformative impact on pharmaceutical policy. As we reflect on these past 4 years, the...

The 118th Congress is wrapping...

12/18/2024

First Report Managed Care

Behind the Bill

Medicare Privatization Under New CMS Leadership: What's Really at Stake

12/11/2024

Katie Hayes , MJ;

After writing about Dr Oz's potential impact on Medicare drug negotiations last week, I found myself diving deeper into an aspect of his nomination that deserves closer attention: his vision for Medicare's future. A letter from Senate...

After writing about Dr Oz's...

12/11/2024

First Report Managed Care

Behind the Bill

Medicare Drug Negotiations Under New CMS Leadership

12/04/2024

Katie Hayes , MJ;

President-elect Donald Trump nominated Dr Mehmet Oz to lead the Centers for Medicare & Medicaid Services (CMS). With this potential change in leadership, are there any implications for Medicare’s drug price negotiation program,...

President-elect Donald Trump...

12/04/2024

First Report Managed Care

Behind the Bill

When Recess Isn’t a Break: What NLRB v Canning Means for HHS

11/20/2024

Katie Hayes , MJ;

As Robert F. Kennedy Jr’s nomination for Secretary of Health and Human Services (HHS) moves through the Senate, there’s growing discussion about whether a recess appointment could be used to bypass confirmation challenges. The Supreme Court’s...

As Robert F. Kennedy Jr’s...

11/20/2024

First Report Managed Care